CarthroniX Completes Convertible Note Financing - Press Release
Proceeds Will Support Pre-clinical Development and Clinical Advancement of its Lead Candidate, CX-011, for the Treatment of Mild to Moderate Knee Oste
Source: wiredprnews.com
Stay updated with breaking news from Moderate Knee. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Proceeds Will Support Pre-clinical Development and Clinical Advancement of its Lead Candidate, CX-011, for the Treatment of Mild to Moderate Knee Oste
/PRNewswire/ -- CarthroniX, Inc., a California-based startup developing novel small molecule modulators of the cell surface receptor gp130, today announced the...